Protein-coding regions
Broad coding-region analysis across approximately 20,000 genes.
Broad analysis of protein-coding regions across approximately 20,000 genes, guided by the clinical question and relevant medical history.
Understanding the test
Whole exome sequencing examines protein-coding regions across approximately 20,000 genes to help investigate suspected inherited conditions. Interpretation can focus on a clinical presentation or selected panel areas, including neurodevelopmental, neurological, diabetes, eye, cancer and immune conditions. This breadth can be useful when several genes may explain a presentation. Ask Genomika about the analysis scope, coverage of a particular gene and the most suitable testing approach.
Exome enrichment followed by next-generation sequencing and clinically directed analysis of coding-region variants.
What is included
This is an exome-wide assay rather than a fixed panel. Approximately 20,000 coding genes describes the broad assay scope; it is not a guarantee that every exon or every variant is covered. Ask for gene-specific coverage and the analysis scope.
Broad coding-region analysis across approximately 20,000 genes.
Analysis of coding-region sequence changes within the selected reportable scope.
Panel-based interpretation for neurodevelopmental, neurological, diabetes, eye, cancer and immune presentations.
In clinical context
Choosing a test means considering both the genes or regions examined and the types of changes it can detect.
Your next step
We’ll discuss the clinical question and confirm testing arrangements, sample requirements, costs and reporting times.